Antimicrobial Resistance of F4+ Escherichia Coli Isolated from Swine in Italy

被引:26
作者
Luppi, A. [1 ]
Bonilauri, P. [1 ]
Dottori, M. [1 ]
Gherpelli, Y. [1 ]
Biasi, G. [1 ]
Merialdi, G. [1 ]
Maioli, G. [1 ]
Martelli, P. [2 ]
机构
[1] IZSLER, I-25124 Brescia, Italy
[2] Univ Parma, Dept Anim Hlth, I-43100 Parma, Italy
关键词
pig; F4+Escherichia coli; antimicrobial resistance; disc diffusion; ANTIBIOTIC-RESISTANCE; PIGS; ENTEROCOCCI;
D O I
10.1111/tbed.12081
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Four-hundred and forty-two F4+ pathogenic Escherichia coli were isolated in a period of 10 years (2002-2011), from pigs that were suffering from diarrhoea belonging to Italian swine herds. The strains were analysed for their susceptibility to 12 antimicrobials using the disc diffusion method. During the study period, a statistically significant proportion of isolates resistant to enrofloxacin (14.5-89.3%), marbofloxacin (5.4 60.7%), flumequine (49.1 92.9%), danofloxacin (21.6-80%), florfenicol (9.8-64.3%), thiamphenicol (50-92%) and cefquinome (3.8-44%) was recorded. An increase in resistance (not statistically significant) to gentamicin (63.6-85.7%), apramycin (61.8-82.1%), trimethoprim-sulphamethoxazole (75-89.3%), tetracycline (97-100%) and erythromycin (92.4-100%) was also observed. Based on antimicrobial multiresistance, the strains were collected into three groups: I. resistant to 2-5 antimicrobials; II. resistant to 6-8 antimicrobials; III. resistant to 9-12 antimicrobials. The number of isolates belonging to the first group showed a statistically significant decrease (P < 0.05; R-2 = 0.896; r = -0.9608), while the isolates belonging to the second and third groups showed a statistically significant increase in resistance (P < 0.05; R-2 = 0.753; r = 0.8890 and P < 0.05; R-2 = 0.727; r = 0.8701, respectively) over the period of study. The results of this study suggest the need for continued monitoring of the development of resistance.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 23 条
  • [1] Aarestrup Frank M., 2008, Animal Health Research Reviews, V9, P135, DOI 10.1017/S1466252308001503
  • [2] [Anonymous], 2008, Performance standards for antimicrobial testing. 18th Informational supplement M100-S18
  • [3] [Anonymous], 2002, Approved Standard-Second Edition
  • [4] document M31-A2
  • [5] Burch D, 2005, IN PRACTICE, V27, P37
  • [6] CASFM, 2010, COMMUNIQUE
  • [7] Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus
    Fitzgibbon, JE
    John, JF
    Delucia, JL
    Dubin, DT
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2122 - 2124
  • [8] Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi
    Intorre, L.
    Vanni, M.
    Di Bello, D.
    Pretti, C.
    Meucci, V.
    Tognetti, R.
    Soldani, G.
    Cardini, G.
    Jousson, O.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2007, 30 (05) : 464 - 469
  • [9] Correlation between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicin-resistant Escherichia coli
    Jensen, Vibeke F.
    Jakobsen, Lotte
    Emborg, Hanne-Dorthe
    Seyfarth, Anne Mette
    Hammerum, Anette M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (01) : 101 - 107
  • [10] GENTAMICIN RESISTANCE IN CLINICAL ISOLATES OF ESCHERICHIA-COLI ENCODED BY GENES OF VETERINARY ORIGIN
    JOHNSON, AP
    BURNS, L
    WOODFORD, N
    THRELFALL, EJ
    NAIDOO, J
    COOKE, EM
    GEORGE, RC
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1994, 40 (03) : 221 - 226